Doxycycline Recall: Hyclate 100 mg tablets
Announced 2026-05-13 · FDA
FDA recall notice for Doxycycline Hyclate Tablets, USP 100 mg, 500-count Rx bottles distributed nationwide by Acella Pharmaceuticals, LLC (NDC 42192-501-05). The recall is due to failed dissolution specifications found in stability testing for Lot P24ZLK1 (exp 5/31/2027). About 4,680 bottles are affected.
| Brand | Acella Pharmaceuticals, LLC |
|---|---|
| Product | Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05. |
| Reason | Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications. |
| Severity | moderate |
| Units affected | 6336 |
| Distribution | Nationwide in the USA |
| Agency | FDA |
| Recall / campaign no. | Lot #: P24ZLK1, Exp 5/31/2027 |
WHAT YOU SHOULD DO
- Check if you have Doxycycline Hyclate 100 mg tablets from Acella with Lot P24ZLK1; verify the lot and expiration.
- If your bottle is affected, stop using it and contact your healthcare provider or pharmacist for guidance.
- Return or dispose of the product according to FDA recall instructions or your pharmacy's guidance.
- If you have questions, contact Acella Pharmaceuticals, LLC or the FDA recall information line.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.